Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1946 publications
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head &... US$ 5,650.00

... subsegments: Cancer Immunotherapy Market, by Type Monoclonal Antibodies Cancer Vaccines Checkpoint Inhibitors Immunomodulators Cancer Immunotherapy Market, by Application Lung Cancer Breast Cancer Head and Neck Cancer Prostate Cancer Colorectal Cancer Melanoma Others Cancer Immunotherapy Market, by End ...

Sep, 2016 147 pages
US Breast Cancer Drug Market Outlook 2022 US$ 1,800.00

... Breast Cancer Drug Market Outlook 2022” Report Highlights: US Breast Cancer Tendencies US Breast Cancer Drug Market Outline US Breast Cancer Drug Market Dynamics Breast Cancer Risk Undercurrents US Breast Cancer Marketed Drugs Clinical Insight by Company & Patent Analysis US Breast Cancer Marketed ...

Sep, 2016 130 pages
Vulvar Cancer Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H2, 2016' provides an overview of Vulvar Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvar Cancer. Report includes an overview of trial ...

Jul, 2016 82 pages
Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Metastatic Prostate Cancer Global Clinical Trials Review, H2, 2016' provides an overview of Metastatic Prostate Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Prostate Cancer. Report includes an overview of trial ...

Jul, 2016 315 pages
Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016' provides an overview of Metastatic Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Ovarian Cancer. Report includes an overview of trial ...

Jul, 2016 104 pages
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016' provides an overview of Metastatic Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Breast Cancer. Report includes an overview of trial ...

Jul, 2016 1889 pages
Global Intracranial Pressure Monitoring Market 2016-2020 US$ 2,500.00

... perfusion pressure (CPP) is essential, and the use of ICP monitoring reduces mortality in case of severe head injuries. Technavio’s analysts forecast the global intracranial pressure (ICP) monitoring market ... monitors to hospitals and trauma centers. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Intracranial Pressure (ICP) Monitoring Market ...

Sep, 2016 87 pages
Global Breast Cancer Monoclonal Antibodies Market 2016-2020 US$ 2,500.00

... the clones of a single parent cell. Technavio’s analysts forecast the global breast cancer monoclonal antibodies (mAbs) market to post a revenue of 13.7 billion by 2020. Covered in this report ... used to treat breast cancer. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Breast Cancer Monoclonal Antibodies (mAbs) Market ...

Sep, 2016 88 pages
Global Oncology Consult Market Research Report 2016 US$ 2,850.00

2016 Global Oncology Consult Market Report is a professional and in-depth research report on the world's major regional market conditions of the Oncology Consult industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Oncology Consult industry; 3.) the North American Oncology Consult industry; 4.) the European Oncology Consult industry; 5.) market entry and investment feasibility; and ...

Sep, 2016 151 pages
Global Hormone Refractory Breast Cancer Market Research Report 2016 US$ 2,850.00

2016 Global Hormone Refractory Breast Cancer Market Report is a professional and in-depth research report on the world's major regional market conditions of the Hormone Refractory Breast Cancer industry, focusing on the ... with: 1.) basic information; 2.) the Asia Hormone Refractory Breast Cancer industry; 3.) the North American Hormone Refractory Breast Cancer industry; 4.) the European Hormone Refractory Breast Cancer industry; 5.) market entry and investment feasibility ...

Sep, 2016 151 pages
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK US$ 19,700.00

... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

Sep, 2016 820 pages
2016 Spain Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 6,800.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 565 pages
2016 Japan Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 7,600.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 590 pages
2016 Italy Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 6,800.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 570 pages
2016 Germany Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 6,800.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 585 pages
2016 France Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 6,800.00

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 585 pages
2016 US Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 9,800.00

... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 620 pages
2016 UK Cancer Diagnostics Market: Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies US$ 6,800.00

... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

Sep, 2016 565 pages
Global Urinary Tract Cancer Market Report 2016 US$ 2,850.00

2016 Global Urinary Tract Cancer Market Report is a professional and in-depth research report on the world's major regional market conditions of the Urinary Tract Cancer industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Urinary Tract Cancer industry; 3.) the North American Urinary Tract Cancer industry; 4.) the European Urinary Tract Cancer industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 148 pages
Global Non Small-Cell Lung Cancer Market Report 2016 US$ 2,850.00

2016 Global Non Small-Cell Lung Cancer Market Report is a professional and in-depth research report on the world's major regional market conditions of the Non Small-Cell Lung Cancer industry, focusing on the ... with: 1.) basic information; 2.) the Asia Non Small-Cell Lung Cancer industry; 3.) the North American Non Small-Cell Lung Cancer industry; 4.) the European Non Small-Cell Lung Cancer industry; 5.) market entry and investment feasibility ...

Aug, 2016 148 pages
Multiple Myeloma - US Drug Forecast and Market Analysis to 2023 US$ 4,995.00

Multiple Myeloma - US Drug Forecast and Market Analysis to 2023 Summary The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is ... the changing competitive landscape for Multiple Myeloma. Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential ...

Nov, 2015 164 pages
Multiple Myeloma - Japan Drug Forecast and Market Analysis to 2023 US$ 4,995.00

Multiple Myeloma - Japan Drug Forecast and Market Analysis to 2023 Summary The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is ... the top drugs in Japan from 2014-2024. Analysis of the impact of key events as well the drivers and restraints affecting Japan Multiple Myeloma market. Reasons ...

Nov, 2015 162 pages
Multiple Myeloma - Current and Future Players US$ 2,995.00

Multiple Myeloma - Current and Future Players Summary GlobalData has released its pharma report, “Multiple Myeloma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Myeloma Market ...

Nov, 2015 83 pages
Multiple Myeloma - China Drug Forecast and Market Analysis to 2023 US$ 4,995.00

Multiple Myeloma - China Drug Forecast and Market Analysis to 2023 Summary The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is ... the top drugs in China from 2014-2024. Analysis of the impact of key events as well the drivers and restraints affecting China Multiple Myeloma market. Reasons ...

Nov, 2015 161 pages
Multiple Myeloma - 5EU Drug Forecast and Market Analysis to 2023 US$ 6,995.00

Multiple Myeloma - 5EU Drug Forecast and Market Analysis to 2023 Summary The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is ... the top drugs in 5EU from 2014-2024. Analysis of the impact of key events as well the drivers and restraints affecting 5EU Multiple Myeloma market. Reasons ...

Nov, 2015 175 pages
Global Lung Cancer Therapeutics Market Report 2016 US$ 2,850.00

2016 Global Lung Cancer Therapeutics Report is a professional and in-depth research report on the world's major regional market conditions of the Lung Cancer Therapeutics industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Lung Cancer Therapeutics industry; 3.) the North American Lung Cancer Therapeutics industry; 4.) the European Lung Cancer Therapeutics industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Global Cervical Cancer Diagnostic Market Report 2016 US$ 2,850.00

2016 Global Cervical Cancer Diagnostic Report is a professional and in-depth research report on the world's major regional market conditions of the Cervical Cancer Diagnostic industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Cervical Cancer Diagnostic industry; 3.) the North American Cervical Cancer Diagnostic industry; 4.) the European Cervical Cancer Diagnostic industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Global Cancer Therapeutics and Biotherapeutic Market Report 2016 US$ 2,850.00

2016 Global Cancer Therapeutics and Biotherapeutic Report is a professional and in-depth research report on the world's major regional market conditions of the Cancer Therapeutics and Biotherapeutic industry, focusing ... : 1.) basic information; 2.) the Asia Cancer Therapeutics and Biotherapeutic industry; 3.) the North American Cancer Therapeutics and Biotherapeutic industry; 4.) the European Cancer Therapeutics and Biotherapeutic industry; 5.) market entry and ...

Aug, 2016 146 pages
Global Cancer Genome Sequencing Market Report 2016 US$ 2,850.00

2016 Global Cancer Genome Sequencing Report is a professional and in-depth research report on the world's major regional market conditions of the Cancer Genome Sequencing industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Cancer Genome Sequencing industry; 3.) the North American Cancer Genome Sequencing industry; 4.) the European Cancer Genome Sequencing industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016 US$ 3,500.00

... FDC or CD223 or LAG3) - Pipeline Review, H2 2016 SUMMARY Global Markets Direct’s, ‘Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016’, provides in depth analysis on Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) targeted pipeline therapeutics ...

Jul, 2016 51 pages
Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight US$ 2,400.00

... Angiogenesis Inhibitors Metronomic Therapy - A Recent Advancement in Anti-Angiogenesis Therapy Global Cancer Angiogenesis Inhibitors Clinical Pipeline by Company, Indication & Phase Global Cancer Angiogenesis Inhibitors Clinical Pipeline: 146 Drugs Marketed Cancer Angiogenesis Inhibitors Drugs: 11 Drugs ...

Aug, 2016 660 pages
Thyroid Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Thyroid Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Testicular cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Testicular cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Oropharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Oropharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Oral Mucositis - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Oral Mucositis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Nasopharyngeal Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Nasopharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Myelodysplastic Syndrome- Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Myelodysplastic Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Lip and Oral Cavity Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Lip and Oral Cavity Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Lip and Oral Cavity Cancer ...

Sep, 2016 100 pages
Larynx Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Larynx Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Human Papillomavirus (HPV) market. Identifying patient populations in the global “Human Papillomavirus (HPV)market to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Gastrointestinal Stromal Tumors (GIST)- Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gastrointestinal Stromal Tumors (GIST) market. Identifying patient populations in the global “Gastrointestinal Stromal Tumors (GIST)market to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Gastric Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gastric Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Gallbladder Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gallbladder Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Esophageal Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Esophageal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chronic Myelocytic Leukemia (CML) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Myelocytic Leukemia (CML ...

Sep, 2016 100 pages
Chemotherapy Induced Neutropenia  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chemotherapy Induced Neutropenia market. Identifying patient populations in the global “Chemotherapy Induced Neutropeniamarket to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Chemotherapy Induced Nausea and Vomiting  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chemotherapy Induced Nausea and Vomiting forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Nausea and Vomiting ...

Sep, 2016 100 pages
1 2 3 4 5 >
Skip to top